1. Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse;Sievers;J Clin Oncol,2001
2. An updated report of the efficacy and safety of gemtuzumab ozogamicin in 188 patients with acute myeloid leukemia in first relapse;Stadtmauer;Proc Am Soc Clin Oncol,2001
3. Analysis of predisposing factors for hepatic veno-occlusive disease after treatment with gemtuzumab ozogamicin Mylotarg®, CMA-676);Stadtmauer;Blood,2001
4. Carboplatin infusion in relapsed and refractory acute myeloid leukemia–a Southwest Oncology Group trial;Welborn;Leukemia,1995
5. Probability of long-term diseasefree survival for acute myeloid leukemia patients after first relapse: a single-centre experience;Vignetti;Ann Oncol,1996